ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1376

Low Vitamin D Level Is Not Associated With Increased Incidence Of Rheumatoid Arthritis

Jonida Cote1, Androniki Bili1, H. Lester Kirchner2 and Xiaoqin Tang3, 1Rheumatology, Geisinger Medical Center, Danville, PA, 2Geisinger Center for Health Research, Geisinger Health System, Danville, PA, 3Biostatistics, Geisinger Center for Health Research, Danville, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Vitamin D and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Vitamin D is thought to be an immunomodulator able to suppress autoimmunity in rheumatoid arthritis (RA).  Some reports describe an association between low vitamin D and RA, but they had significant limitations. The objective of this study was to evaluate the association of vitamin D level with incident RA in a well characterized patient population using electronic health records (EHR).

Methods: Case-control study with data extracted from EHR in a tertiary health system, from 2001 to 2012. RA was defined as ICD-9 code 714.0 twice by a rheumatologist. Only patients with a primary care physician in the system were included. Incident RA patients (cases) were identified at one point in time and followed retrospectively with regard to vitamin D levels prior to the development of RA.  Cases were matched for age and gender with 5 controls from the general non-RA population.  An index date was created such that for cases it was the date of the RA diagnosis and for the controls it was the date of the RA diagnoses of the matched case.  The most recent value of vitamin D to the index date was used in the analysis. Vitamin D levels were treated both as continuous and categorical; we used <30 IU as the primary cutoff, but also used <20 IU to investigate the RA association with severe vitamin D deficiency. This association was presented as the odds ratio (OR) from a conditional logistic regression model adjusting for obesity and smoking status. The study had a power of 82% to detect an OR of 1.5 between cases and controls.

Results: 270 patients with incident RA and 1341 matched controls were included in the analysis with median age 62.4 years, BMI 28.8 kg/m2and vitamin D level 31 IU. There were no significant differences in median BMI and vitamin D levels between cases and controls. Smoking was significantly more prevalent in the cases than the controls. Of the RA patients, 141 (52.2%) were rheumatoid factor (RF) positive, 97 (35.9%) were RF negative, and 32 (11.9%) had unavailable RF status. The OR for the association between RA and vitamin D overall and stratified by gender is shown in Table 1. Subgroup analysis according to RF positivity is shown in Table 2.

Conclusion: Low vitamin D level was not associated with increased odds for incident RA in this patient population. Our study was powered at 80% to detect a minimum of 50% increase in the odds of low vitamin D levels.

Table 1. Association between low vitamin D level and Rheumatoid arthritis according to gender*

 Vitamin D level

All

Female

Male

 

OR (95% CI)

p-value

OR (95% CI)

p-value

OR (95% CI)

p-value

Vitamin D (continuous)

0.996
 (0.987, 1.005)

0.3652

 0.996
(0.985, 1.006)

0.4014

0.997
(0.976, 1.018)

0.7693

Vitamin D <30 IU vs.  ≥ 30 IU

0.980
(0.745, 1.288)

0.8825

0.924
(0.682, 1.254)

0.6134

1.233
(0.649, 2.343)

0.5231

Vitamin D <20 IU vs. ≥ 20 IU

1.121

(0.801, 1.570)

0.5048

1.192

(0.825, 1.724)

0.3493

0.860

(0.362, 2. 045)

0.7336

*adjusted for smoking, BMI (kg/m2)

Table 2. Association between low vitamin D and Rheumatoid Arthritis according to Rheumatoid Factor positivity*

 Vitamin D level

RF-positive vs. controls

RF-negative vs. controls

 

OR (95% CI)

p-value

OR (95% CI)

p-value

Vitamin D (continuous)

0.991
 (0.978, 1.005)

0.1945

0.997
(0.981, 1.013)

0.6974

Vitamin D <30 IU vs. ≥30 IU

1.062
(0.723, 1.561)

0.7594

0.810
(0.503, 1.304)

0.3854

Vitamin D <20 IU vs. ≥20 IU

1.244
(0.790, 1.961)

0.3464

0.789
 (0.415, 1.502)

0.4710

*adjusted for smoking, BMI (kg/m2); RF=rheumatoid factor


Disclosure:

J. Cote,
None;

A. Bili,
None;

H. L. Kirchner,
None;

X. Tang,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/low-vitamin-d-level-is-not-associated-with-increased-incidence-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology